Lauro Ferreira da Silva Pinto Neto
Research Subjects
Research Interests
Lauro Ferreira da Silva Pinto Neto has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Angélica Espinosa Miranda
Universidade Federal do Espirito Santo
5 shared publications - Alice Vervloet da Luz
Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória (EMESCAM). Curso de Medicina. Vitória – ES - Brasil
1 shared publication Andressa Costa Braga
Santa Casa de Misericórdia de Vitória
1 shared publicationAndréa Teixeira-Carvalho
Grupo Integrado de Pesquisas Em Biomarcadores, Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ-Minas), Belo Horizonte, Brazil
1 shared publication- Antonio Higor Freire de Morais
Instituto Federal de Educação, Ciência e Tecnologia do Rio Grande do Norte - Professor
1 shared publication Bil Randerson Bassetti
Curso de Medicina, Escola Superior de Ciências, Santa Casa de Misericórdia de Vitória, ES
1 shared publication
Latest Publications
- Open Access
- 30 September 2023
- Published by Elsevier in IJID Regions
- Vol. 9, 88-94
Half dose ChAdOx1 nCoV-19 vaccine was equivalent to full doses to reduce moderate and severe COVID-19 cases
- 30 September 2023
- Published by Elsevier in IJID Regions
- Vol. 9, 88-94
Open AccessHalf dose ChAdOx1 nCoV-19 vaccine was equivalent to full doses to reduce moderate and severe COVID-19 cases
- Open Access
- 24 June 2022
- Published by Fundacao Arnaldo Vieira de Carvalho in Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo
- p. 1 of 5
Hepatite E: / Hepatitis E: literature review
Introdução: A hepatite E representa uma doença viral de distribuição global, sendo uma das causas mais frequentes de hepatite aguda em todo o mundo. Objetivo: Desenvolver uma revisão bibliográfica referente à hepatite E. Método: Pesquisa qualitativa, descritiva de revisão da literatura narrativa. Os bancos de dados foram PubMed e Scielo a partir do termo “Hepatite E” em artigos publicados nos últimos cinco anos e selecionados 23 trabalhos. Discussão: O agente etiológico pertence ao gênero Orthohepevirus da família Hepeviridae, a qual inclui 8 genótipos e um sorotipo. A prevalência dos genótipos varia com a região geográfica, sendo os genótipos 1 e 2 mais prevalentes em regiões emergentes e 3 e 4 em países desenvolvidos. O quadro clínico compreende pacientes assintomáticos àqueles que evoluem com hepatite aguda fulminante. Sabe-se que a hepatite E pode cronificar, especialmente em imunocomprometidos. As manifestações incluem sintomas extra-hepáticos, com predileção neurológica e renal. A transmissão da doença ocorre por fontes de água contaminadas, contato direto com animais e consumo de alimentos contaminados. Odiagnóstico pode ser realizado pela pesquisa de anticorpos contra o vírus ou quantificação do RNA viral. O tratamento baseia-se em medidas de suporte, sendo preconizado ouso de terapia antiviral somente em situações especiais. A principal forma de prevenção é a vacinação. Ademais disso, investimento em saneamento básico e melhora na qualidadede alimentos contribuem para diminuição de casos. Conclusões: A Hepatite E consiste em uma crescente causa de hepatite aguda, especialmente em países emergentes; logo,profissionais de saúde devem considerar o diagnóstico entre os demais quadros de acometimento hepático, sugerindo estudos acerca do tema.Palavras Chave: Hepatite E, Insuficiência hepática, Vírus da hepatite E AbstractIntroduction: Hepatitis E represents a disease with global distribution, being one of the most frequent causes of acute hepatitis worldwide. Objective: Develop a literature reviewregarding hepatitis E. Method: Qualitative and descriptive review of narrative literature. The databases were PubMed and Scielo, using the term “Hepatitis E” searching for articles published in the last five years, selecting 23 of them. Discussion: Hepatitis E represents a viral disease with global distribution. The etiological agent belongs to the genus Orthohepevirus of the Hepeviridae family, which includes 8 genotypes and 1 serotype. The prevalence of each genotypes varies by geographic region, with genotypes 1 and 2 beingmore prevalent in emerging regions and 3 and 4 in developed countries. The clinical picture ranges from asymptomatic patients to those who develop fulminant acute hepatitis. Itis known that hepatitis E can become chronic, especially in immunocompromised patients. Manifestations include extrahepatic symptoms, with neurological and renal predilection. Disease transmission occurs through contaminated water sources, direct contact with animals and consumption of contaminated food. Diagnosis can be made by virus antibodies screening or quantification of viral RNA. Treatment is based on supportive measures, and the use of antiviral therapy is recommended only in special situations. The main prophylaxis is vaccination. Furthermore, investment in basic sanitation and improvement in food quality contribute to the reduction of cases. Conclusions: Hepatitis E is a growing cause of acute hepatitis, especially in emerging countries. Therefore, health professionals should considerthis diagnosis among other conditions of liver involvement, suggesting studies about this subject. Keywords: Hepatitis E, Hepatic insufficiency, Hepatitis E virus
- 24 June 2022
- Published by Fundacao Arnaldo Vieira de Carvalho in Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo
- p. 1 of 5
Open AccessHepatite E: / Hepatitis E: literature review
Introdução: A hepatite E representa uma doença viral de distribuição global, sendo uma das causas mais frequentes de hepatite aguda em todo o mundo. Objetivo: Desenvolver uma revisão bibliográfica referente à hepatite E. Método: Pesquisa qualitativa, descritiva de revisão da literatura narrativa. Os bancos de dados foram PubMed e Scielo a partir do termo “Hepatite E” em artigos publicados nos últimos cinco anos e selecionados 23 trabalhos. Discussão: O agente etiológico pertence ao gênero Orthohepevirus da família Hepeviridae, a qual inclui 8 genótipos e um sorotipo. A prevalência dos genótipos varia com a região geográfica, sendo os genótipos 1 e 2 mais prevalentes em regiões emergentes e 3 e 4 em países desenvolvidos. O quadro clínico compreende pacientes assintomáticos àqueles que evoluem com hepatite aguda fulminante. Sabe-se que a hepatite E pode cronificar, especialmente em imunocomprometidos. As manifestações incluem sintomas extra-hepáticos, com predileção neurológica e renal. A transmissão da doença ocorre por fontes de água contaminadas, contato direto com animais e consumo de alimentos contaminados. Odiagnóstico pode ser realizado pela pesquisa de anticorpos contra o vírus ou quantificação do RNA viral. O tratamento baseia-se em medidas de suporte, sendo preconizado ouso de terapia antiviral somente em situações especiais. A principal forma de prevenção é a vacinação. Ademais disso, investimento em saneamento básico e melhora na qualidadede alimentos contribuem para diminuição de casos. Conclusões: A Hepatite E consiste em uma crescente causa de hepatite aguda, especialmente em países emergentes; logo,profissionais de saúde devem considerar o diagnóstico entre os demais quadros de acometimento hepático, sugerindo estudos acerca do tema.Palavras Chave: Hepatite E, Insuficiência hepática, Vírus da hepatite E AbstractIntroduction: Hepatitis E represents a disease with global distribution, being one of the most frequent causes of acute hepatitis worldwide. Objective: Develop a literature reviewregarding hepatitis E. Method: Qualitative and descriptive review of narrative literature. The databases were PubMed and Scielo, using the term “Hepatitis E” searching for articles published in the last five years, selecting 23 of them. Discussion: Hepatitis E represents a viral disease with global distribution. The etiological agent belongs to the genus Orthohepevirus of the Hepeviridae family, which includes 8 genotypes and 1 serotype. The prevalence of each genotypes varies by geographic region, with genotypes 1 and 2 beingmore prevalent in emerging regions and 3 and 4 in developed countries. The clinical picture ranges from asymptomatic patients to those who develop fulminant acute hepatitis. Itis known that hepatitis E can become chronic, especially in immunocompromised patients. Manifestations include extrahepatic symptoms, with neurological and renal predilection. Disease transmission occurs through contaminated water sources, direct contact with animals and consumption of contaminated food. Diagnosis can be made by virus antibodies screening or quantification of viral RNA. Treatment is based on supportive measures, and the use of antiviral therapy is recommended only in special situations. The main prophylaxis is vaccination. Furthermore, investment in basic sanitation and improvement in food quality contribute to the reduction of cases. Conclusions: Hepatitis E is a growing cause of acute hepatitis, especially in emerging countries. Therefore, health professionals should considerthis diagnosis among other conditions of liver involvement, suggesting studies about this subject. Keywords: Hepatitis E, Hepatic insufficiency, Hepatitis E virus
- Open Access
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 54 (suppl 1) , e2020588
Brazilian Protocol for Sexually Transmitted Infections, 2020: HIV infection in adolescents and adults
HIV infection is presented in the chapters of the Clinical Protocol and Therapeutic Guidelines for Comprehensive Care for People with Sexually Transmitted Infections, published by the Brazilian Ministry of Health in 2020. Health professionals and managers must learn the signs and symptoms of HIV infection and know how to diagnose it to provide appropriate treatment and reduce complications. HIV infection has become a chronic disease. Its treatment includes addressing common comorbidities such as arterial hypertension, diabetes, and dyslipidemia, in addition to cardiac risk assessment, cancer prevention, and guidance on immunization. Initiation of treatment for HIV patients is recommended regardless of clinical or immunological criteria as adopted by the Ministry of Health since 2013. Lately, it has been simplified with more tolerable first-line medications and fewer drug interactions, making its management easy to implement, including by primary health care. HIV cases are concentrated in specific population groups, such as sex workers, men who have sex with men, transexuals, people who use alcohol or other drugs, and vulnerable people, such as black, incarcerated, or people living on the streets.
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 54 (suppl 1) , e2020588
Open AccessBrazilian Protocol for Sexually Transmitted Infections, 2020: HIV infection in adolescents and adults
HIV infection is presented in the chapters of the Clinical Protocol and Therapeutic Guidelines for Comprehensive Care for People with Sexually Transmitted Infections, published by the Brazilian Ministry of Health in 2020. Health professionals and managers must learn the signs and symptoms of HIV infection and know how to diagnose it to provide appropriate treatment and reduce complications. HIV infection has become a chronic disease. Its treatment includes addressing common comorbidities such as arterial hypertension, diabetes, and dyslipidemia, in addition to cardiac risk assessment, cancer prevention, and guidance on immunization. Initiation of treatment for HIV patients is recommended regardless of clinical or immunological criteria as adopted by the Ministry of Health since 2013. Lately, it has been simplified with more tolerable first-line medications and fewer drug interactions, making its management easy to implement, including by primary health care. HIV cases are concentrated in specific population groups, such as sex workers, men who have sex with men, transexuals, people who use alcohol or other drugs, and vulnerable people, such as black, incarcerated, or people living on the streets.
- Open Access
- 19 July 2017
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 21 (6) , 577-580
Comparison of the ACC/AHA and Framingham algorithms to assess cardiovascular risk in HIV-infected patients
- 19 July 2017
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 21 (6) , 577-580
Open AccessComparison of the ACC/AHA and Framingham algorithms to assess cardiovascular risk in HIV-infected patients
- Open Access
- 1 June 2017
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 21 (5) , 515-519
Vaccination coverage in a cohort of HIV-infected patients receiving care at an AIDS outpatient clinic in Espírito Santo, Brazil
- 1 June 2017
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 21 (5) , 515-519
Open AccessVaccination coverage in a cohort of HIV-infected patients receiving care at an AIDS outpatient clinic in Espírito Santo, Brazil
- Open Access
- 25 November 2015
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 20 (1) , 99-102
Human immunodeficiency virus infection and its association with sarcopenia
- 25 November 2015
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 20 (1) , 99-102
Open AccessHuman immunodeficiency virus infection and its association with sarcopenia
- Open Access
- 21 November 2015
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 20 (1) , 14-18
Nephrotoxicity during tenofovir treatment: a three-year follow-up study in a Brazilian reference clinic
- 21 November 2015
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 20 (1) , 14-18
Open AccessNephrotoxicity during tenofovir treatment: a three-year follow-up study in a Brazilian reference clinic
- Open Access
- 2 June 2013
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 17 (4) , 438-443
Dyslipidemia and fasting glucose impairment among HIV patients three years after the first antiretroviral regimen in a Brazilian AIDS outpatient clinic
- 2 June 2013
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 17 (4) , 438-443
Open AccessDyslipidemia and fasting glucose impairment among HIV patients three years after the first antiretroviral regimen in a Brazilian AIDS outpatient clinic
- Open Access
- 1 December 2012
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 45 (6) , 687-690
Malignancies in HIV/AIDS patients attending an outpatient clinic in Vitória, State of Espírito Santo, Brazil
The present study investigated cancer prevalence and associated factors among HIV-infected individuals attending an AIDS outpatient clinic in Vitória, State of Espírito Santo, Brazil. A sectional study was conducted among HIV infected adults attending an AIDS outpatient clinic in Vitória, State of Espírito Santo, Brazil. Demographic, epidemiological and clinical data were abstracted from medical records, including cancer diagnoses; nadir and current CD4 cell count, HIV viral load, time on antiretroviral treatment (ART), type of ART and smoking status. A total of 730 (91.3%) patients were included in the study. Median age was 44.0 [interquartile range (IQR): 35–50.3] years; median time since HIV diagnosis was 5.5 years (IQR: 2–10); 60% were male; and 59% were white. Thirty (4.1%) cases of cancer were identified of which 16 (53%) were AIDS defining cancers and 14 (47%) were non-AIDS defining malignancies. Patients diagnosed with cancer presented higher chance of being tobacco users [OR 2.2 (95% CI: 1.04–6.24)]; having nadir CD4 ≤200 cells/mm3 [OR 3.0 (95% CI: 1.19–7.81)] and higher lethality [OR 13,3 (95% CI: 4,57–38,72)]. These results corroborate the importance of screening for and prevention of non-AIDS defining cancers focus in HIV-infected population, as these cancers presented with similar frequency as AIDS defining cancers.
- 1 December 2012
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 45 (6) , 687-690
Open AccessMalignancies in HIV/AIDS patients attending an outpatient clinic in Vitória, State of Espírito Santo, Brazil
The present study investigated cancer prevalence and associated factors among HIV-infected individuals attending an AIDS outpatient clinic in Vitória, State of Espírito Santo, Brazil. A sectional study was conducted among HIV infected adults attending an AIDS outpatient clinic in Vitória, State of Espírito Santo, Brazil. Demographic, epidemiological and clinical data were abstracted from medical records, including cancer diagnoses; nadir and current CD4 cell count, HIV viral load, time on antiretroviral treatment (ART), type of ART and smoking status. A total of 730 (91.3%) patients were included in the study. Median age was 44.0 [interquartile range (IQR): 35–50.3] years; median time since HIV diagnosis was 5.5 years (IQR: 2–10); 60% were male; and 59% were white. Thirty (4.1%) cases of cancer were identified of which 16 (53%) were AIDS defining cancers and 14 (47%) were non-AIDS defining malignancies. Patients diagnosed with cancer presented higher chance of being tobacco users [OR 2.2 (95% CI: 1.04–6.24)]; having nadir CD4 ≤200 cells/mm3 [OR 3.0 (95% CI: 1.19–7.81)] and higher lethality [OR 13,3 (95% CI: 4,57–38,72)]. These results corroborate the importance of screening for and prevention of non-AIDS defining cancers focus in HIV-infected population, as these cancers presented with similar frequency as AIDS defining cancers.
- Open Access
- 1 February 2011
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 44 (1) , 30-34
Fatores de risco associados a alterações renais em pacientes infectados por HIV-1
INTRODUÇÃO: A doença renal é uma das principais comorbidades envolvendo pacientes infectados com o HIV, em razão da melhora da sobrevida proporcionada pela terapêutica antirretroviral. O objetivo deste estudo foi detectar fatores de risco, possivelmente correlacionados com função renal alterada, em pacientes infectados pelo HIV. MÉTODOS: Estudo transversal foi realizado em 254 pacientes infectados pelo HIV, atendidos em ambulatório na Santa Casa de Vitória. Eles foram entrevistados e submetidos a coletas de amostras de sangue para contagem de células CD4, quantificação de carga viral do HIV-1, dosagens de glicose, lipídeos e creatinina. A proteinúria foi avaliada em amostra de primeira urina da manhã. A filtração glomerular foi estimada com as fórmulas de modified diet in renal disease (MDRD) simplificada e Cockcroft-Gault. RESULTADOS: Cento e três (40,6%) pacientes tinham alguma anormalidade no exame de urina, sendo proteinúria o achado mais comum (46; 18,1% pacientes). Vinte e cinco (9,8%) pacientes tinham filtração glomerular estimada inferior a 60ml/min/1.73m² de acordo com MDRD. A análise de regressão logística multivariada mostrou que baixa filtração glomerular foi positivamente correlacionada com raça negra [OR 9,6 (IC95% 1,28-23,80)], hipertensão arterial sistêmica [OR 3,3 (IC95% 1,28-23,81)], idade acima de 51 anos [OR 3,3 (IC95%1,11-9,90)], proteinúria [OR 5,2 {IC95% 1,67-16,25}]; hematúria [OR 3,2 (1,12-9,29)] e negativamente com pacientes em uso de zidovudina [OR 0,2 (0,04-0,78)]. CONCLUSÕES: Os fatores de risco tradicionais para doença renal como raça negra, hipertensão arterial e idade avançada foram correlacionados com menor filtração glomerular estimada em nossos pacientes.
- 1 February 2011
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 44 (1) , 30-34
Open AccessFatores de risco associados a alterações renais em pacientes infectados por HIV-1
INTRODUÇÃO: A doença renal é uma das principais comorbidades envolvendo pacientes infectados com o HIV, em razão da melhora da sobrevida proporcionada pela terapêutica antirretroviral. O objetivo deste estudo foi detectar fatores de risco, possivelmente correlacionados com função renal alterada, em pacientes infectados pelo HIV. MÉTODOS: Estudo transversal foi realizado em 254 pacientes infectados pelo HIV, atendidos em ambulatório na Santa Casa de Vitória. Eles foram entrevistados e submetidos a coletas de amostras de sangue para contagem de células CD4, quantificação de carga viral do HIV-1, dosagens de glicose, lipídeos e creatinina. A proteinúria foi avaliada em amostra de primeira urina da manhã. A filtração glomerular foi estimada com as fórmulas de modified diet in renal disease (MDRD) simplificada e Cockcroft-Gault. RESULTADOS: Cento e três (40,6%) pacientes tinham alguma anormalidade no exame de urina, sendo proteinúria o achado mais comum (46; 18,1% pacientes). Vinte e cinco (9,8%) pacientes tinham filtração glomerular estimada inferior a 60ml/min/1.73m² de acordo com MDRD. A análise de regressão logística multivariada mostrou que baixa filtração glomerular foi positivamente correlacionada com raça negra [OR 9,6 (IC95% 1,28-23,80)], hipertensão arterial sistêmica [OR 3,3 (IC95% 1,28-23,81)], idade acima de 51 anos [OR 3,3 (IC95%1,11-9,90)], proteinúria [OR 5,2 {IC95% 1,67-16,25}]; hematúria [OR 3,2 (1,12-9,29)] e negativamente com pacientes em uso de zidovudina [OR 0,2 (0,04-0,78)]. CONCLUSÕES: Os fatores de risco tradicionais para doença renal como raça negra, hipertensão arterial e idade avançada foram correlacionados com menor filtração glomerular estimada em nossos pacientes.